Addus HomeCare Co. (NASDAQ:ADUS) Shares Bought by Oliver Luxxe Assets LLC

Oliver Luxxe Assets LLC grew its position in Addus HomeCare Co. (NASDAQ:ADUS) by 3.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,056 shares of the company’s stock after buying an additional 544 shares during the quarter. Oliver Luxxe Assets LLC owned 0.09% of Addus HomeCare worth $2,138,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in ADUS. Quarry LP purchased a new position in Addus HomeCare during the 3rd quarter valued at about $28,000. Quest Partners LLC acquired a new stake in shares of Addus HomeCare in the second quarter valued at approximately $31,000. Farther Finance Advisors LLC increased its stake in shares of Addus HomeCare by 9,150.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares in the last quarter. Sandia Investment Management LP acquired a new position in shares of Addus HomeCare during the 2nd quarter worth approximately $58,000. Finally, GAMMA Investing LLC lifted its stake in Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock valued at $124,000 after buying an additional 191 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analyst Ratings Changes

Several research firms have weighed in on ADUS. Stephens raised their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Oppenheimer boosted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. Macquarie reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Royal Bank of Canada reissued an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Finally, StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Addus HomeCare presently has a consensus rating of “Buy” and an average target price of $133.67.

Addus HomeCare Price Performance

NASDAQ:ADUS traded up $0.53 during trading hours on Monday, reaching $125.12. 107,222 shares of the company were exchanged, compared to its average volume of 124,511. The firm has a market cap of $2.27 billion, a price-to-earnings ratio of 28.63, a PEG ratio of 2.11 and a beta of 1.00. The stock has a 50 day simple moving average of $125.12 and a 200 day simple moving average of $125.83. Addus HomeCare Co. has a 52-week low of $85.94 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same period last year, the company posted $1.03 EPS. The business’s quarterly revenue was up 7.1% on a year-over-year basis. On average, analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Insider Activity

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the sale, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 39,750 shares of company stock valued at $4,930,750 in the last three months. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.